UNSPSC 51143900: Stimulant or anorexiant alcohols

This classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term STIMULANT OR ANOREXIANT ALCOHOLS.

UNSPSC 51143900 Stimulant or anorexiant alcohols is a Class code that in current state and local procurement activity names naloxone and drug deactivation systems, generic pharmaceuticals, and prescription fulfillment services — a significant divergence from the code's nominal scope. State and local health agencies, cooperative purchasing alliances, and county health departments are the primary issuing bodies. Recent solicitations show county-level procurement (Seminole County, Florida) for emergency-response pharmaceuticals, state health commission market research (Texas HHS), and multistate cooperative purchasing for pharmaceutical distribution (Minnesota Multistate Cooperative Purchasing Alliance covering Minnesota and Oregon).

Activity concentrates in Florida, Texas, and the Upper Midwest, with the most recent opportunities spanning from April 2026 through late July 2026. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with bids due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, requesting vendor capabilities for direct-to-manufacturer prescription programs to support pharmacy benefit initiatives, functioning as exploratory market intelligence before a formal RFP. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance, issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic pharmaceuticals and OTC products through authorized wholesalers with responses due March 26, 2026 and contract effectiveness July 1, 2026. The code appears to misclassify the actual pharmaceutical and health-services procurement occurring under it; vendors pursuing opportunities should verify category alignment with each issuing body's specific scope before submitting responses.